These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9471020)

  • 21. Monoethylglycinexylidide formation measurement as a hepatic function test to assess severity of chronic liver disease.
    Testa R; Caglieris S; Risso D; Arzani L; Campo N; Alvarez S; Giannini E; Lantieri PB; Celle G
    Am J Gastroenterol; 1997 Dec; 92(12):2268-73. PubMed ID: 9399768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis.
    Bhise SB; Dias RJ
    Indian J Gastroenterol; 2007; 26(4):167-9. PubMed ID: 17986743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monoethylglycinexylidide (MEGX) test in patients with different liver diseases.
    Gruttadauria S; Marino G; Russello M; Gentile A; Denaro Papa F; Gruttadauria G
    Ann Ital Chir; 1998; 69(2):211-4. PubMed ID: 9718790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 13C-methacetin breath test correlates with clinical indices of liver disease severity in patients with primary biliary cirrhosis.
    Kochel-Jankowska A; Hartleb M; Jonderko K; Kaminska M; Kasicka-Jonderko A
    J Physiol Pharmacol; 2013 Feb; 64(1):27-33. PubMed ID: 23568968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
    Kuiper EM; Hansen BE; de Vries RA; den Ouden-Muller JW; van Ditzhuijsen TJ; Haagsma EB; Houben MH; Witteman BJ; van Erpecum KJ; van Buuren HR;
    Gastroenterology; 2009 Apr; 136(4):1281-7. PubMed ID: 19208346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of hepatic lidocaine metabolism to monitor patients with chronic liver disease.
    Shiffman ML; Luketic VA; Sanyal AJ; Thompson EB
    Ther Drug Monit; 1996 Aug; 18(4):372-7. PubMed ID: 8857553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of lidocaine metabolism to test liver function during the long-term follow-up of liver transplant recipients.
    Conti F; Dousset B; Cherruau B; Guérin C; Soubrane O; Houssin D; Calmus Y
    Clin Transplant; 2004 Jun; 18(3):235-41. PubMed ID: 15142042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of the monoethylglycinexylidide test in pediatric liver transplant candidates.
    Burdelski M; Schütz E; Nolte-Buchholtz S; Armstrong VW; Oellerich M
    Ther Drug Monit; 1996 Aug; 18(4):378-82. PubMed ID: 8857554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lignocaine metabolite formation as a measure of pre-transplant liver function.
    Oellerich M; Burdelski M; Ringe B; Lamesch P; Gubernatis G; Bunzendahl H; Pichlmayr R; Herrmann H
    Lancet; 1989 Mar; 1(8639):640-2. PubMed ID: 2564460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monoethylglicinexylidide test: a prognostic indicator of survival in cirrhosis.
    Arrigoni A; Gindro T; Aimo G; Cappello N; Meloni A; Benedetti P; Molino GP; Verme G; Rizzetto M
    Hepatology; 1994 Aug; 20(2):383-7. PubMed ID: 8045499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Value of an extended monoethylglycinexylidide formation test and other dynamic liver function tests in liver transplant donors.
    Zotz RB; von Schönfeld J; Erhard J; Breuer N; Lange R; Beste M; Goebell H; Eigler FW
    Transplantation; 1997 Feb; 63(4):538-41. PubMed ID: 9047147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of MEGX (monoethylglycinexylidide) and antipyrine tests in patients with liver cirrhosis.
    Wojcicki J; Kozlowski K; Drozdzik M; Wojcicki M
    Eur J Drug Metab Pharmacokinet; 2002; 27(4):243-7. PubMed ID: 12587953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of the monoethylglycinexylidide liver function test in assessing donor liver suitability.
    Fairchild R; Solomon H; Contis J; Kaminski D
    Arch Surg; 1996 Oct; 131(10):1099-102. PubMed ID: 8857911
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operative risk by the lidocaine test (MEGX) in resected patients for HCC on cirrhosis.
    Ravaioli M; Grazi GL; Principe A; Ercolani G; Cescon M; Gardini A; Varotti G; Del Gaudio M; Cavallari A
    Hepatogastroenterology; 2003; 50(53):1552-5. PubMed ID: 14571784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis?
    Kilmurry MR; Heathcote EJ; Cauch-Dudek K; O'Rourke K; Bailey RJ; Blendis LM; Ghent CN; Minuk GY; Pappas SC; Scully LJ; Steinbrecher UP; Sutherland LR; Williams CN; Worobetz LJ
    Hepatology; 1996 May; 23(5):1148-53. PubMed ID: 8621147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Evaluation of lidocaine metabolite (monoethylglycinexylidide) as a liver function test].
    Shimanuki K; Suzuki W; Sakurabayashi I; Kiyozaki H; Shinohara K; Soda K; Kai T; Satake M; Miyata M
    Nihon Shokakibyo Gakkai Zasshi; 1993 Jan; 90(1):33-40. PubMed ID: 8433534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis and life expectancy in primary biliary cirrhosis].
    Zangerl G; Propst T; Propst A; Judmaier G; Vogel W; Braunsteiner H
    Wien Klin Wochenschr; 1994; 106(4):93-6. PubMed ID: 8165815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis.
    Testa R; Campo N; Caglieris S; Risso D; Alvarez S; Arzani L; Giannini E; Lantieri PB; Celle G
    Hepatogastroenterology; 1998; 45(19):154-9. PubMed ID: 9496506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of determination of monoethylglycinexylidide (MEGX)--as a liver function test in hepatology and liver transplantation].
    Kupcová V
    Bratisl Lek Listy; 1999 Jan; 100(1):49-53. PubMed ID: 10492998
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis.
    Herold C; Ganslmayer M; Deynet C; Hahn EG; Schuppan D
    Liver; 2002 Apr; 22(2):159-65. PubMed ID: 12028411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.